药物分子的晚期和阶段
De-Hai Liu1, Philipp M Pflüger2, Andrew Outlaw3
1Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering and Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200240, P. R. China.
Journal of the American Chemical Society
|April 15, 2024
概括
研究人员开发了温和的化学方法,将平面芳香药物转化为3D和分子,改善药物的特性. 这种方法通过增加可溶性和代谢稳定性来增强药物发现.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药物发现 药物发现 药物发现
背景情况:
- 现代药品通常含有通过交叉合反应合成的平坦的脂性芳香环 (sp2碳).
- 这些结构特征可以降低药物的有效性,溶解性和代谢稳定性,阻碍药物开发.
- 将芳香结构转换为和类型 (sp3碳) 可以增强药用特性.
研究的目的:
- 为和芳香和异芳香药物开发高效和温和的方法.
- 通过增加药物分子的三维性和碳含量来提高药物分子的药用特性.
- 证明这些方法在复杂药物化合物的后期功能化中的实用性.
主要方法:
- 轻度催化化. 轻度催化化.
- 通过酸介导的减少.
- 光催化化. 光催化化.
主要成果:
- 成功地将芳香和异芳香药物转化为具有改善药用特性的和类型.
- 证明了复杂的生产,3D和药品与多样化的功能组.
- 768种复杂小分子药物的验证后期和 (LSS),与DMSO储存条件相容.
结论:
- 温和的催化方法可以有效地和芳香药物,增强它们的类似药物的特性.
- 这些转换适用于各种化学空间,产生3D分子.
- 开发的方法,特别是催化化,与制药化合物库兼容,促进药物发现和优化.
相关概念视频
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
164
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
164
Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
63
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
63
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Nonlinear Pharmacokinetics: Causes of Nonlinearity
179
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
179
Nonlinear Pharmacokinetics: Overview
361
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
361


